Their glucose-dependent mechanism of action helps reduce blood sugar without driving it dangerously low
A genetic test can clarify whether dose escalation or switching to GLP-Squared (dual therapy) would better match your peptide-pathway profile
Three-month treatment works best as a starting point for lifestyle change rather than a standalone solution
Semaglutide, in particular, has attracted intense public interest, while prior evidence cited by the authors suggests greater weight-management effectiveness than older GLP-1RAs
Also, although there is clinical event reduction data at lower doses in diabetics, getting these data at higher doses in obesity will be very important, especially to support insurers paying a substantial part of the cost of this medication. Also important to learn, Neeland said, is that what is not known, and is not able to be known from the STEP program, are whether there are select benefits in patients with excess visceral adiposity as opposed to excess subcutaneous fat where the fat is in the body, is that related to the weight-loss response, and is it, potentially, then related to the CV benefit? Individualized interventions coupled with the right pharmacotherapy are key, though that often involves trial and error, Stanford said
I had a lipoma removed and was very pleased with the work
